Test for abnormal niacin response syndrome in schizophrenia: reclaiming the oral route / Prueba de síndrome de respuesta a niacina anormal en pacientes con diagnóstico de esquizofrenia: reivindicando la vía oral.

Introduction: Although there is an abnormal presentation of Niacin Response Syndrome (ANRS) in schizophrenic patients (SZ) compared to subjects with other psychiatric illnesses and with healthy individuals. However, most of the literature is based on studies that have used tests of niacin topical administration, observing, on the other hand, less scientific production of its oral administration. The objective was to determine the sensitivity of the oral niacin test as a method of detecting ASRN in EZ. Methods: A non-randomized clinical trial was carried out. Two groups were formed, the experimental or SZ, with 21 patients diagnosed with schizophrenia according to DSM-IV-TR SZ or schizoaffective disorder, and the HC group, made up of 20 healthy controls. Both groups were exposed to an oral niacin test and clinical-semiological tools were applied to evaluate the NRS. Results: 90.5% of the SZ group presented ANRS. In contrast, no participant in the HC group presented ANRS (0%). Conclusions: Oral niacin administration was sensitive to the detection of ASRN in schizophrenia. Likewise, ASRN could be a gradual phenomenon and its prevalence could be dose-dependent, being lower the lower the dose of oral niacin used. Further trials with larger and randomized samples will be needed.

Introducción: En pacientes esquizofrénicos (EZ) existe un síndrome de respuesta a niacina (ASRN) anormal en comparación con sujetos con otras enfermedades psiquiátricas y con individuos sanos. Sin embargo, la mayor parte de la literatura se basa en estudios que han utilizado pruebas de niacina por vía tópica, observándose, en cambio, menor cantidad de ensayos utilizando su administración por vía oral, a pesar de existir algunas ventajas comparativas con el uso de esta última vía. El objetivo fue determinar la sensibilidad de la prueba de niacina por vía oral como método de detección del ASRN en EZ. Metodología: Se realizó un ensayo clínico no aleatorizado, conformando dos grupos, el grupo experimental o EZ, con 21 pacientes con diagnóstico de esquizofrenia según DSM-IV-TR SZ o trastorno esquizoafectivo, y el grupo CS, constituido por 20 controles sanos. Ambos grupos fueron expuestos a la prueba de niacina por vía oral y se aplicaron herramientas clínico-semiológicas para evaluar el SRN. Resultados: La prevalencia de ASRN fue del 90,5% en el grupo EZ, mientras que en el grupo CS fue nula (0%). Conclusiones: La administración oral de niacina fue sensible a la detección de ASRN en la esquizofrenia. Asimismo, la ASRN podría ser un fenómeno gradual y su prevalencia podría ser dosis-dependiente, siendo menor cuanto menor sea la dosis de niacina oral utilizada. Se necesitarán ensayos adicionales con muestras de mayor tamaño y aleatorizadas.

Vitamina D: entre el brillo del sol y la oscuridad de la depresión / Vitamin D: Between the Brightness of the sun and the Darkness of Depression

RESUMEN Introducción: La literatura científica indica que hay relación entre la vitamina D (VitD) y el inicio, el tratamiento y el pronóstico de la depresión. Sin embargo, esta línea de investigación continúa siendo motivo de controversia. El propósito del trabajo es analizar la relación entre la depresión y los valores de VitD, controlando por la influencia de la estación. Material y métodos: Estudio observacional y transversal. La muestra quedó conformada por 150 voluntarias adultas (edad, 28-78 arios). Se estratificó la muestra en 3 grupos: depresión sin tratamiento, depresión en tratamiento con antidepresivos y sin depresión (control). Se compararon los valores de VitD. Resultados: Se hallaron diferencias significativas entre los 3 grupos de comparación. El grupo con depresión sin tratamiento obtuvo los valores de VitD más bajos (media, 18,62 ± 8,42 ng/ml), compatibles con una insuficiencia grave. El grupo de participantes con depresión en tratamiento obtuvo valores más altos que el grupo anterior, aunque en la franja de insufi ciencia (23,80 ± 11,30 ng/ml). El tercer grupo (control) obtuvo los valores más altos y acordes con el intervalo deseable (30,19 ± 10,21 ng/ml). No hubo diferencias de edad entre los grupos. Al controlar por posibles efectos de la estación del año, las diferencias previas de VitD entre los 3 grupos se mantuvieron, con un descenso ostensible de todas las medias en el periodo invernal. Conclusiones: La depresión se asocia con valores de VitD insuficientes. El tratamiento con antidepresivos mejora esos valores, aunque continúan siendo insuficientes. Los hallazgos de este estudio refuerzan la evidencia de una asociación entre la depresión y la VitD.

ABSTRACT Introduction: The scientific literature suggests a relationship between vitamin D (VitD) and the onset, treatment and prognosis of depression. However, this line of research continues to be controversial. The aim of the study was to analyse the relationship between depression and VitD values, controlling for the influence of the season. Material and methods: Observational and cross-sectional study. The sample was made up of 150 adult female volunteer participants (aged between 28 and 78 years). The sample was stratified into three groups: a) depression without treatment, b) depression under treat ment with antidepressants, and c) without depression (control). VitD values (ng/ml) were compared. Results: Significant differences were found between the three groups surveyed. The group of participants with depression without treatment obtained the lowest VitD values (mean 18.62 ng/ml; SD 8.42), compatible with severe insufficiency. The group of participants with depression in treatment obtained higher values than the previous group, although in an insufficient range (mean 23.80 ng/ml; SD 11.30). The third group (control) obtained the hig hest values and in accordance with the desirable range (mean 30.19 ng/ml; SD 10.21). There were no age differences between the groups. When controlling for possible effects of the season, the previous differences in VitD between the three groups were maintained, with an evident decrease of all the mean levels in the winter period. Conclusions: Depression is associated with insufficient VitD values. Treatment with antidepressants improves these values, although they continue to be insufficient. The findings of this study reinforce the evidence for an association between depression and VitD.

Functional capacity and cognitive performance of adults from Argentina in cardiopulmonary rehabilitation / Capacidad funcional y rendimiento cognitivo de adultos argentinos en rehabilitación cardiopulmonar.

Introduction: Functional capacity is decreased in people with Cardiovascular Diseases and Chronic Respiratory Diseases. These diseases have also been associated with cognitive dysfunction. The study examines the efficacy of a cardiopulmonary rehabilitation program in the recovery of functional capacity and analyzes whether subjects with cardiopulmonary diseases suffer from cognitive dysfunction. Materials and methods: Participated 50 adults with medium-high education who completed a cardiopulmonary rehabilitation program of between 3 and 6 months based on physical education, nutritional education, promotion of healthy habits and medication management. Functional capacity was evaluated with the Duke index at the beginning and end of the program. Memory and language tests were also administered, for the only time, at the beginning of the program, comparing the values obtained with Argentine normative studies. The data was analyzed with the Wilcoxon test, bivariate correlations, and linear regression. Results: Functional capacity increased significantly at the end of the program. In any case, the post-program Duke value suggests that the functional capacity of the patients continues to be affected. On the other hand, a memory test explained 10,8% of the variance in the Duke index, and there are no findings of cognitive dysfunction. Conclusion: The functional capacity of cardiopulmonary patients improved with the rehabilitation program, although this improvement is clinically insufficient. Better memory performance predicted greater functional capacity, which is why it is suggested to add cognitive stimulation workshops to cardiopulmonary rehabilitation programs. This sample with cardiopulmonary disease does not present cognitive dysfunction, probably due to its high cognitive reserve. Introduction: Functional capacity is decreased in people with Cardiovascular Diseases and Chronic Respiratory Diseases. These diseases have also been associated with cognitive dysfunction. The study examines the efficacy of a cardiopulmonary rehabilitation program in the recovery of functional capacity and analyzes whether subjects with cardiopulmonary diseases suffer from cognitive dysfunction. Materials and methods: Participated 50 adults with medium-high education who completed a cardiopulmonary rehabilitation program of between 3 and 6 months based on physical education, nutritional education, promotion of healthy habits and medication management. Functional capacity was evaluated with the Duke index at the beginning and end of the program. Memory and language tests were also administered, for the only time, at the beginning of the program, comparing the values obtained with Argentine normative studies. The data was analyzed with the Wilcoxon test, bivariate correlations, and linear regression. Results: Functional capacity increased significantly at the end of the program. In any case, the post-program Duke value suggests that the functional capacity of the patients continues to be affected. On the other hand, a memory test explained 10,8% of the variance in the Duke index, and there are no findings of cognitive dysfunction. Conclusion: The functional capacity of cardiopulmonary patients improved with the rehabilitation program, although this improvement is clinically insufficient. Better memory performance predicted greater functional capacity, which is why it is suggested to add cognitive stimulation workshops to cardiopulmonary rehabilitation programs. This sample with cardiopulmonary disease does not present cognitive dysfunction, probably due to its high cognitive reserve.

Introducción: La capacidad funcional está disminuida en personas con Enfermedades Cardiovasculares y Enfermedades Respiratorias Crónicas. Estas enfermedades también han sido asociadas a disfunción cognitiva. El estudio examina la eficacia de un programa de rehabilitación cardiopulmonar en la recuperación de la capacidad funcional, y analiza si sujetos con enfermedades cardiopulmonares sufren disfunción cognitiva. Materiales y métodos: Participaron 50 personas adultas con instrucción media-alta que completaron un programa de rehabilitación cardiopulmonar de entre 3 y 6 meses basado en educación física, educación nutricional, promoción de hábitos saludables y manejo de medicación. Se evaluó la capacidad funcional con el índice Duke al iniciar y finalizar el programa. Se administró también, por única vez, al iniciar el programa, pruebas de memoria y de lenguaje, comparando los valores obtenidos con estudios normativos argentinos. Se analizó los datos con test Wilcoxon, correlaciones bivariadas y regresión lineal. Resultados: La capacidad funcional aumentó significativamente al finalizar el programa. De todos modos el valor Duke pos- programa sugiere que la capacidad funcional de los pacientes continúa afectada. Por otro lado, una prueba de memoria explicó el 10,8% de la varianza en el índice Duke, y no hay hallazgos de disfunción cognitiva. Conclusión: La capacidad funcional de los pacientes cardiopulmonares mejoró con el programa de rehabilitación, aunque dicha mejora, es clínicamente insuficiente. Mejor rendimiento de memoria predijo mayor capacidad funcional, por lo que se sugiere añadir talleres de estimulación cognitiva a los programas de rehabilitación cardiopulmonares. Esta muestra con enfermedad cardiopulmonar no presenta disfunción cognitiva, probablemente por su elevada reserva cognitiva.

Reproductive aging and executive functions in healthy women.

The aim of this study was to analyze the influence of reproductive aging on executive functions. We assessed executive functions in three groups of healthy women in the premenopausal (n = 45, mean age = 30.89, SD = 10.5), perimenopausal (n = 31, mean age = 50.06, SD = 3.6) and postmenopausal (n = 24, mean age = 63.39, SD = 6.5) phase. No differences between groups were observed in working memory, verbal fluency, inhibitory control, planning, and cognitive flexibility. However, when the analyses were repeated with participants with occupations with lower intellectual demands, perimenopausal and postmenopausal women performed worse than premenopausal women in semantic verbal fluency. This study provides important evidence to understand the effects of reproductive aging on cognitive performance in healthy women. Our findings indicate that cognitive reserve-related factors may be important to understand the differences in executive functions associated with reproductive aging.

[Atrial natriuretic peptide: its relationship with anxiety and depression]. / Péptido natriurético atrial: su relación con la ansiedad y la depresión.

The Atrial Natriuretic Peptide (ANP) is a hormone secreted by the heart, and, due to its mechanisms in the central nervous system, it is credited with a possible anxiolytic and stress-reducing effect. The aim of this study consisted of examining the values of ANP in adults and its relationship with anxiety and depression. An exploratory, observational and cross-sectional study was adopted. The sample was composed by 30 attending a Mental Health Service. The Beck Anxiety Inventory and the Beck Depression Inventory were applied, and a negative association between ANP values and the depressive state under Beck scale (p=0.017) was observed, more precisely lower ANP levels in patients with Beck's severe depression state. There were no relevant associations between ANP values and Beck's anxiety states. In order to reinforce this research topic, it is necessary to perform longitudinal studies, gather wider samples and include biological indicators for anxiety and depression as alpha-amylase and cortisol.

[A short review of four key physiopathological mechanisms for psychosomatic medicine]. / Breve revisión de cuatro mecanismos fisiopatológicos claves para la Medicina Psicosomática.

The notion that "psychological factors " and the psychosocial environment influence the body function and the health maintenance or disease onset has been maintained over the years, and from different approaches to science, medicine, and psychology. Psychosomatic Medicine traditionally deals with this issue, but the "psychosomatic" name is now being criticized because of some implicit ambiguity, probably derived from the identification with the different theoretical frameworks and/or specific research methods that have been used in its evolution. This has given rise to misunderstandings about its definition, objectives, and a delay in the search for pathways of mediatizing these effects. Since then, there has been an increasing interest in the research of mechanisms, or mediatizing pathways through which the mind, the brain, and the environment could produce an impact on the somatic functioning. This brief review focuses on early stress, epigenetics and polymorphisms, such as the mechanism of penetration of the psychosocial environment; alostasis and alostatic load such as the accumulated wear and tear produced by the continuous adaptation to a variable psicosocial context; activation of the neuroimmune pathways as the physiological basis of somatizations; and interoception as a the pathway that the body introduces into the brain, mind and consciousness.

Síndrome de ovario poliquístico: una revisión de sus correlatos patológicos en el ánimo y en el rendimiento cognitivo / Polycystic ovary syndrome: a review of its pathological correlates in mood and cognitive performance

El Síndrome de ovario poliquístico (SOP) constituye la endocrinopatía más frecuente en las mujeres en edad reproductiva. En los últimos años se avanzó considerablemente en la comprensión clínica y fisiopatológica del SOP. Sin embargo los aspectos comportamentales del SOP continúan siendo menos claros. El objetivo del actual trabajo radicó en revisar las alteraciones en el ánimo y en el rendimiento cognitivo en mujeres con SOP. Se buscaron artículos originales publicados en las bases de datos Pubmed y Science direct (lapso 2006-2015). Se concluye que las mujeres con SOP experimentan con frecuencia depresión y trastornos de ansiedad. El índice de masa corporal resultó el principal predictor de psicopatología. Un estudio longitudinal de grandes dimensiones desestimó un mayor riesgo para trastornos bipolares. Por otro lado algunos estudios señalaron dificultades en el rendimiento cognitivo en mujeres con SOP, particularmente en funciones verbales. En cuanto a un supuesto perfil cognitivo más masculino en el SOP, existen evidencias a favor y evidencias en contra. En fin, no es posible confirmar la presencia de déficits cognitivos, ni tampoco un perfil específico en el SOP, ya que la investigación sobre sus aspectos cognitivos continúa siendo muy escasa. Respecto a los mecanismos explicativos de las alteraciones comportamentales del SOP, se propone la existencia tanto de factores biológicos como psicosocioculturales. Por último, y a raíz de la revisión actual, se sugiere asignar mayor relevancia clínica a los trastornos asociados al ánimo en mujeres con SOP e incrementar la investigación sobre los aspectos cognitivos de esta enfermedad...

Polycystic Ovarian Syndrome (PCOS) is the most common endocrine disease in women of reproductive age. In recent years substantial progress was made in the clinical and pathophysiological understanding of PCOS. However the behavioral aspects of PCOS are still less clear. The aim of the present work was to review the changes in mood and cognitive performance in women with PCOS. We searched for original articles published in the databases Pubmed and Science direct (period 2006-2015). It is concluded that women with PCOS frequently experience depression and anxiety disorders. The body mass index was the main predictor of psychopathology. Meanwhile, a large longitudinal study dismissed an increased risk for bipolar disorder. On the other hand, some studies reported difficulties in cognitive performance in women with PCOS, particularly in verbal functions. As for a course more masculine cognitive profile in the PCOS, there are evidences in favor and against. It is not possible to confirm the presence of cognitive deficits in PCOS , nor a specific profile, because the research on the cognitive aspects of PCOS remains scarce. Regarding mechanisms explanatory of behavioral disturbances in PCOS, it is proposed the existence of biological and psychosocial/cultural factors. Following the current review, it is suggested allocate clinical relevance for mood disorders in women with PCOS and increase research of its cognitive aspects...

La alteración en el patrón de sueño se asocia a la persistencia de síntomas depresivos en pacientes hipotiroideos después del tratamiento con LT4 / The sleep pattern disturbance may be associated to the persistence of depressive symptoms in hypothyroid patients after LT4 treatment

Introduction: Given the frequent association between thyroid hormones and emotional symptoms, the aims of this research were to check the occurrence of depressive symptoms in patients with primary hypothyroidism, to study the reversibility of such symptoms after LT4 treatment and to evaluate the existence of predictive symptoms of response/no-response to LT4 only treatment. Methods: 70 primary hypothyroidism female patients (TSHmean: 16 uU/m0l) were assessed with Beck Depression Inventory (BDI).They were all treated solely with LT4. TSH value was tested after treatment and patients who had previously shown depressive symptoms were re-assessed with BDI. Results: 51.4 percent showed depressive symptoms prior to treatment (TSH: 20.1 uU/ml SE: 4.7; BDI: 23.8 SE: 1.1), 75 percent of those patients showed no symptoms after LT4 treatment (TSH: 1.63 uU/ml SE: 0.28; BDI: 8 SE: 1), but in the remaining 25 percent those symptoms persisted (TSH: 1.25 uU/ml SE: 0,29; BDI24 SE: 2). Sleep disturbance, item 16, is the only factor with significant persistence (p. ≥ 0.045) after treatment. Conclusions: 51.4 percent of the hypothyroidism patients showed depressive symptoms; hypothyroidism treatment was adequate to normalize TSH values in all the cases and to reverse depressive symptoms in 75 percent of them while 25 percent remain with depressive symptoms. Within this group, the persistence of sleep disturbance could be considered to be a predictive, no-response symptom and would point to the need to re-evaluate diagnosis and to consider the addition of another treatment.

Introducción: Dada la frecuente asociación entre hormonas tiroideas y síntomas emocionales, los objetivos de este trabajo fueron verificar la presencia de síntomas depresivos en pacientes con hipotiroidismo primario, estudiar su reversibilidad post tratamiento con LT4 y evaluar la existencia de síntomas predictivos de la respuesta/no respuesta al tratamiento. Métodos: 70 mujeres con hipotiroidismo primario (TSHmedia:16 uU/ml) fueron evaluadas mediante el Cuestionario para Depresión de Beck (BDI), luego del tratamiento del hipotiroidismo se retomó el BDI a las pacientes que hubieran presentado síntomas depresivos en la primera parte del trabajo, se determinó TSH en todas la pacientes pre y post tratamiento. Resultados: 51,4 por ciento de las pacientes hipotiroideas presentaron síntomas depresivos (TSH: 20,1 uU/ml, ES: 4,7; BDI: 23,8, ES: 1,1), 75 por ciento no presentaron síntoma depresivos post tratamiento con LT4 (TSH: 1,63 uU/ml ES 0,28; BDI: 8,ES: 1), pero en el 25 por ciento restante esos síntomas persistieron (TSH: 1,25 uU/ml ES 0,29; BDI: 24, ES: 2). El ítem 16, Dificultad en el sueño, es el único con persistencia significativa (p ≥ 0,045) post tratamiento. Conclusión: el 51,4 por ciento de las pacientes hipotiroideas presentó síntomas depresivos; el tratamiento con LT4 fue el adecuado para normalizar TSH en todos los casos y para revertir los síntomas depresivos en el 75 por ciento de ellos, mientras que en un 25 por ciento los síntomas permanecieron. Dentro de este grupo, el síntoma dificultad en el sueño fue el que persistió significativamente y se podría considerar a esta asociación como un predictor de la falta de respuesta, esto nos estaría indicando que el tratamiento con LT4 solamente no sería eficaz.

[Association between acute coronary events and psychosocial risk factors: vital exhaustion, anxiety and anger in an Argentinian population. A correlation study between risks factors]. / Asociación entre evento coronario y factores de riesgo psicosociales: agotamiento vital, ansiedad e ira en una población de Argentina. Estudio de correlación entre factores de riesgo.

OBJECTIVE: To study the association between vital exhaustion, anxiety and anger with acute coronary event; second, determine whether they are associated with each other, and third, if the joint interaction of two or more factors increases the risk for coronary event. METHOD: We conducted a case-control study with 165 patients, both sexes, between 35 and 75 years, 90 patients with acute ischemic coronary event and 75 controls hospitalized with an acute event of non-ischemic cardiac causes. RESULTS: Statistically significant differences between the control group and the ischemic coronary group for vital exhaustion was found (OR = 3.0 (1.6-5.5) p < 0.001 (chi2)). Psychosocial risk factors are associated each with p < 0.001: anxiety and vital exhaustion (Spearman Rho = 0.58), anger and vital exhaustion (Spearman Rho = 0.41) and anxiety and anger (Spearman Rho = 0.38). The simultaneous presence of vital exhaustion and anxiety increases the probability of an acute ischemic coronary event (p < 0.01). CONCLUSIONS: In this study we found a significative association between vital exhaustion and acute ischemic coronary event, psychosocial risk factors are associated with each other and simultaneous presence of vital exhaustion and anxiety increases the probability of an acute ischemic coronary event.

Asociación entre evento coronario y factores de riesgo psicosociales: agotamiento vital, ansiedad e ira en una población de Argentina. Estudio de correlación entre factores de riesgo. / [Association between acute coronary events and psychosocial risk factors: vital exhaustion, anxiety and anger in an Argentinian population. A correlation study between risks factors].

OBJECTIVE: To study the association between vital exhaustion, anxiety and anger with acute coronary event; second, determine whether they are associated with each other, and third, if the joint interaction of two or more factors increases the risk for coronary event. METHOD: We conducted a case-control study with 165 patients, both sexes, between 35 and 75 years, 90 patients with acute ischemic coronary event and 75 controls hospitalized with an acute event of non-ischemic cardiac causes. RESULTS: Statistically significant differences between the control group and the ischemic coronary group for vital exhaustion was found (OR = 3.0 (1.6-5.5) p < 0.001 (chi2)). Psychosocial risk factors are associated each with p < 0.001: anxiety and vital exhaustion (Spearman Rho = 0.58), anger and vital exhaustion (Spearman Rho = 0.41) and anxiety and anger (Spearman Rho = 0.38). The simultaneous presence of vital exhaustion and anxiety increases the probability of an acute ischemic coronary event (p < 0.01). CONCLUSIONS: In this study we found a significative association between vital exhaustion and acute ischemic coronary event, psychosocial risk factors are associated with each other and simultaneous presence of vital exhaustion and anxiety increases the probability of an acute ischemic coronary event.

Asociación entre evento coronario y factores de riesgo psicosociales: agotamiento vital, ansiedad e ira en una población de Argentina. Estudio de correlación entre factores de riesgo / [Association between acute coronary events and psychosocial risk factors: vital exhaustion, anxiety and anger in an Argentinian population. A correlation study between risks factors].

OBJECTIVE: To study the association between vital exhaustion, anxiety and anger with acute coronary event; second, determine whether they are associated with each other, and third, if the joint interaction of two or more factors increases the risk for coronary event. METHOD: We conducted a case-control study with 165 patients, both sexes, between 35 and 75 years, 90 patients with acute ischemic coronary event and 75 controls hospitalized with an acute event of non-ischemic cardiac causes. RESULTS: Statistically significant differences between the control group and the ischemic coronary group for vital exhaustion was found (OR = 3.0 (1.6-5.5) p < 0.001 (chi2)). Psychosocial risk factors are associated each with p < 0.001: anxiety and vital exhaustion (Spearman Rho = 0.58), anger and vital exhaustion (Spearman Rho = 0.41) and anxiety and anger (Spearman Rho = 0.38). The simultaneous presence of vital exhaustion and anxiety increases the probability of an acute ischemic coronary event (p < 0.01). CONCLUSIONS: In this study we found a significative association between vital exhaustion and acute ischemic coronary event, psychosocial risk factors are associated with each other and simultaneous presence of vital exhaustion and anxiety increases the probability of an acute ischemic coronary event.

[Vital exhaustion is significantly linked to acute coronary events in Argentine population]. / El Agotamiento Vital se encuentra significativamente asociado con Eventos Coronarios Agudos en una población de Argentina.

OBJECTIVE: To determine the strength of the association between the Vital exhaustion syndrome (VES) and acute coronary ischemic events in hospitalized Argentinean sample. METHODS: VES was measured in 180 patients of both sexes, 90 admitted due to an acute coronary ischemic syndrome (AMI or unstable angina) and a control group of 90 admitted due to an acute non-coronary cardiac event. VES was evaluated with the Maastricht questionnaire during the first week of hospitalization. RESULTS: Dividing the sample in two categories: exhausted and non-exhausted, 57 (63,33%) of the coronary were exhausted, while among the non coronary group, 33 were exhausted (36,66%)(OR=3.1 (1.7-5.8)). The exhaustion score was: control mean score: 17,1 (sd 8,96); case mean score: 21,1 (sd10,60) p: 0.006. Dislipemia was another factor with a significant difference: control 27 (30%) case 44 (62%) OR= 2.2 (1.2-4.1) p=0.01. Logistic regression was performed, including an interaction model between DLP and exhaustion, and it did not show a significant effect. CONCLUSIONS: Our results indicate that in Argentina, among other countries as reported in the literature, VES is a psychological condition that is strongly and independent associated to acute coronary events.

El Agotamiento Vital se encuentra significativamente asociado con Eventos Coronarios Agudos en una población de Argentina / Vital Exhaustion is significantly linked to Acute Coronary Events in Argentine population

Objetivo: Determinar la fuerza de la asociación entre el Agotamiento Vital y eventos isquémicos coronarios agudos en una muestra de pacientes argentinos internados. Método: Se midió el Agotamiento mediante el cuestionario de Maastricht en 180 pacientes de ambos sexos, 90 casos con un evento corona río agudo y 90 controles con un evento agudo cardíaco no-isquémico. Se compararon ambos grupos por edad, sexo, estado civil, y educación, Diabetes, Hipertensión Arterial, Tabaquismo, y Dislipemia. Resultados: El 63,33 por ciento, 57 de los casos estaban agotados, en cambio, el 36,66 por ciento, 33 controles estaban agotados (OR= 3.1 (1.7-5.8) p

Objective: To determine the strength of the association between the Vital exhaustion syndrome (VES) and acute coronary ischemic events in hospitalized Argentinean sample. Methods: VES was measured in 180 patients of both sexes, 90 admitted due to an acute coronary ischemic syndrome (AMI or unstable angina) and a control group of 90 admitted due to an acute non-coronary cardiac event VES was evaluated with the Maastricht questionnaire during the first week of hospitalization. Results: Dividing the sample in two categories: exhausted and non-exhausted, 57 (63,33 percent) of the coronary were exhausted, while among the non coronary group, 33 were exhausted (36, 66 percent)(OR=3.1 (1.7-5.8) p<.OO1. The exhaustion score was: control mean score: 17,1 (sd 8,96); case mean score: 21,1 (sd 10,60) p: 0.006. Dislipemia was another factor with a significant difference: control 27 (30 percent) case 44 (62 percent) OR= 2.2 (1.2-4.1) p=O.01. Logistic regression was performed, including an interaction model between DLP and exhaustion, and it did not show a significant effect. Conclusions: Our results indicate that in Argentina, among other countries as reported in the literature, VES is a psychological condition that is strongly and independent associated to acute coronary events.(AU)

El Agotamiento Vital se encuentra significativamente asociado con Eventos Coronarios Agudos en una población de Argentina / Vital Exhaustion is significantly linked to Acute Coronary Events in Argentine population

Objetivo: Determinar la fuerza de la asociación entre el Agotamiento Vital y eventos isquémicos coronarios agudos en una muestra de pacientes argentinos internados. Método: Se midió el Agotamiento mediante el cuestionario de Maastricht en 180 pacientes de ambos sexos, 90 casos con un evento corona río agudo y 90 controles con un evento agudo cardíaco no-isquémico. Se compararon ambos grupos por edad, sexo, estado civil, y educación, Diabetes, Hipertensión Arterial, Tabaquismo, y Dislipemia. Resultados: El 63,33 por ciento, 57 de los casos estaban agotados, en cambio, el 36,66 por ciento, 33 controles estaban agotados (OR= 3.1 (1.7-5.8) p

Objective: To determine the strength of the association between the Vital exhaustion syndrome (VES) and acute coronary ischemic events in hospitalized Argentinean sample. Methods: VES was measured in 180 patients of both sexes, 90 admitted due to an acute coronary ischemic syndrome (AMI or unstable angina) and a control group of 90 admitted due to an acute non-coronary cardiac event VES was evaluated with the Maastricht questionnaire during the first week of hospitalization. Results: Dividing the sample in two categories: exhausted and non-exhausted, 57 (63,33 percent) of the coronary were exhausted, while among the non coronary group, 33 were exhausted (36, 66 percent)(OR=3.1 (1.7-5.8) p<.OO1. The exhaustion score was: control mean score: 17,1 (sd 8,96); case mean score: 21,1 (sd 10,60) p: 0.006. Dislipemia was another factor with a significant difference: control 27 (30 percent) case 44 (62 percent) OR= 2.2 (1.2-4.1) p=O.01. Logistic regression was performed, including an interaction model between DLP and exhaustion, and it did not show a significant effect. Conclusions: Our results indicate that in Argentina, among other countries as reported in the literature, VES is a psychological condition that is strongly and independent associated to acute coronary events.